Q3 2025 Cryoport Inc Earnings Call Transcript

Nov 4, 2025 / 10:00 PM GMT

Release Date Price: $9.22 (+1.99%)

Transcript 10-Q8-K

Key Points

Positve

CryoPort Inc (CYRX) reported double-digit growth in both life sciences services and product segments, with a 36% year-over-year increase in revenue from commercial cell and gene therapy support.
The company expanded its product portfolio with the launch of MVE Biological Solutions' next-generation SC42V and SC43V vapor shippers, featuring innovative technologies for enhanced performance.
CryoPort Inc (CYRX) opened a new state-of-the-art global supply chain center at Charles de Gaulle Airport in Paris, enhancing its ability to serve European and global markets.
The strategic partnership with DHL Group is expected to enhance CryoPort Inc (CYRX)'s positioning in the APAC and EMEA regions, leveraging DHL's global scale.
The company is progressing on growth initiatives, including the onboarding of clients at its crop preservation services in Belgium and Texas, and anticipates significant revenue generation from these services.

Negative

The high end of CryoPort Inc (CYRX)'s guidance implies a sequential decline in revenues despite positive business momentum.
The ongoing U.S. government shutdown is causing delays in filing activities, which could impact the timing of revenue recognition.
There is some tentativeness around financing in the gene therapy space, which could affect long-term opportunities.
CryoPort Inc (CYRX) has not assumed any growth in China for 2026, indicating potential limitations in expanding into this significant market.
The company faces balancing growth initiatives with achieving profitability, as new facilities and strategic investments may impact short-term margins.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYRX.OQ - Cryoport Inc
Q3 2025 Cryoport Inc Earnings Call
Nov 04, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Cryoport's 3rd quarter 2025 earnings conference call. All participants will start in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press 0 for the operator. As a reminder, this call is being recorded. I will now turn the call over to your host, Todd Frommer from KCSA Strategic Communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Before we begin today, I would like to remind everyone that this

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.